We invest in growth companies in the "late-stage venture/growth capital" phase, focussed on the technology and healthtech sectors.
Business Model: B2B
Revenue: $0
Employees: 0-0
Address: Bahnhofstrasse 9
City: Zurich
State: zurich
Zip: 8001
Country: CH
Swisscanto is an asset management company that offers investment solutions for individuals and businesses.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2019 | GetYourGuide | Secondary Market | - |
6/2021 | Sulzer Schmid | Series B | - |
7/2020 | Beekeeper | Series B | 10M |
1/2021 | 1plusX, a TripleLift company | Series B | 7.8M |
5/2021 | MedTrace Pharma | Venture Round | 0 |
5/2019 | GetYourGuide | Series E | 484M |
8/2019 | SWISSto12 | Series B | 18.4M |
8/2020 | Varjo | Series C | 0 |
11/2020 | Memo Therapeutics | Series B | 15.6M |
1/2022 | Fotokite | Series B | 0 |
9/2019 | Versantis | Series B | 0 |
2/2022 | Memo Therapeutics | Series B | 0 |
1/2023 | tado° | Venture Round | 0 |
11/2021 | Beekeeper | Series C | 0 |
11/2021 | Beekeeper | Convertible Note | 10.5M |
5/2023 | ANYbotics | Series B | 0 |
2/2020 | OncoDNA | Series B | 0 |
5/2023 | ecoRobotix | Series B | 0 |
11/2022 | Beekeeper | Series C | 0 |
9/2019 | Beekeeper | Series B | 45M |
2/2022 | Memo Therapeutics | Series B | 0 |
1/2022 | Fotokite | Series B | 0 |
6/2021 | Sulzer Schmid | Series B | - |
5/2021 | MedTrace Pharma | Venture Round | 0 |
1/2021 | 1plusX, a TripleLift company | Series B | 0 |
11/2020 | Memo Therapeutics | Series B | 0 |
8/2020 | Varjo | Series C | 0 |
7/2020 | Beekeeper | Series B | 0 |
2/2020 | OncoDNA | Series B | 0 |
9/2019 | Versantis | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|